Xanthadrene

by NewtonEverett · capsule · 90 vegetarian capsules

  • On the market (NIH)
  • UPC 8 18423 02808 8
  • DSLD label 248879
  • Serving 1 vegetarian capsule
  • 90 servings

Xanthadrene by NewtonEverett lists 4 ingredients, 1 with an amount per serving of 1 vegetarian capsule, such as 5 mg of brown seaweed powder extract; 3 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on June 23, 2021.

What is in Xanthadrene?

Each row as the label prints it, per serving of 1 vegetarian capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Xanthadrene: Supplement Facts rows against the market (DSLD label 248879, January 2026 release)
IngredientAmount% DVAmong products listing it
Xanthadrene Blend283 mg
Hoodiain the blend, no amount given
Green Tea extractin the blend, no amount given
Pomegranate extractin the blend, no amount given
Brown Seaweed powder extractas Fucoxanthin5 mg

Source: NIH ODS Dietary Supplement Label Database, label 248879 (entered June 23, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 3 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records 3 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Xanthadrene's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: As a dietary supplement, take 1 capsule, 3 times daily with food and 8 ounces of water. This product should be used in conjunction with a sensible diet and exercise program. Do not exceed 3 capsules per day.
Warnings
Warning: If you are pregnant or lactating, consult a healthcare professional before using this product.
Keep out of reach of children.
Do not use this product if safety seal has been broken.
Allergens and what it does not contain
Gluten free Non-GMO Dairy free
Storage
Store in a cool dry place.

Source: label statements in DSLD label 248879.

What else is on the label?

Other ingredients: Rice Flour, Hydroxypropyl Methylcellulose, Vegetable Magnesium Stearate.

How many labels does Xanthadrene have?

One label is on file, entered on June 23, 2021.

  1. Label 248879 (current) Entered June 23, 2021 · on the market · 90 vegetarian capsules · UPC 8 18423 02808 8

DSLD also links this label to: Xanthadrene 288 mg (image difference, same product).

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Newton-Everett Nutraceuticals (distributor), Scottsdale, AZ. All NewtonEverett products.

Where next?